Answers are grounded in this paper and cite their sources.
Background People living with human immunodeficiency virus (HIV) infection (PLWH) have more comorbidities and higher mortality than their non-HIV counterparts, in spite of their improving survival. Aim This study aimed to: 1) characterize a cohort of PLWH using real-world data from the public health system users in Aragon region, Spain; 2) compare the prevalence of specific long-term conditions between PLWH and a matched cohort of people not living with HIV (PNLWH); 3) determine the association between HIV infection and these conditions, controlling for key confounders (sex, year of birth, geographic area, socioeconomic status, and country of birth); and 4) determine whether PLWH are diagnosed with other new comorbidities earlier than PNLWH. Methods and Findings Retrospective observational matched cohort study of 8,302 PLWH matched 1:2 in Aragon, Spain. PLWH had higher multimorbidity burden (median 2 (interquartile range 1, 5) vs 2 (0, 4), increasing with age especially in women, and experienced approximately twice the mortality observed among PNLWH (20,8% in PLWH vs 8,6% in PNLWH). Mental health problems, cardiovascular events, neoplasms and hepatic diseases were more common in PLWH, and these conditions were recorded earlier compared with PNLWH. In men LWH under 45 years, depression showed an adjusted odds ratio (OR) of 2.23 (1.73–2.88). In women LWH aged 45–65 years, congestive heart failure showed an adjusted OR of 60.9 (8.70–426.06). They tended to be diagnosed less frequently with classic cardiovascular risk factors like obesity, or dyslipidemia (OR 0.74 [0.67–0.83] in males aged 45–65 years). Conclusions PLWH experienced a higher burden of morbidity and approximately twice the mortality rate of PNLWH. They were also diagnosed with new chronic conditions at an earlier age than PNLWH. Although PLWH had a higher incidence of cardiovascular events, they had fewer recorded diagnoses of certain cardiovascular risk factors. The existence of different comorbidity profiles in both cohorts shows us that further investigation is needed to assess the influence of HIV infection with respect to the diagnosis and management of comorbidities.
No takes yet. Share an insight, caveat, or question.
Peribáñez-García et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: